SHINE Medical Technologies, LLC
| Published date | 27 November 2019 |
| Citation | 84 FR 65424 |
| Record Number | 2019-25788 |
| Section | Notices |
| Court | Nuclear Regulatory Commission |
Federal Register, Volume 84 Issue 229 (Wednesday, November 27, 2019)
[Federal Register Volume 84, Number 229 (Wednesday, November 27, 2019)]
[Notices]
[Pages 65424-65426]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25788]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-608; NRC-2019-0173]
SHINE Medical Technologies, LLC
AGENCY: Nuclear Regulatory Commission.
ACTION: Intent to prepare a supplement to the final environmental
impact statement and conduct scoping.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) intends to gather
information through the public scoping process to prepare a supplement
the to the final environmental impact statement (FEIS) on the
construction permit related to the operating license application for
the SHINE Medical Isotope Production Facility. The NRC is seeking
public input on the proposed action and has scheduled a public scoping
meeting.
DATES: Submit comments by January 13, 2020. Comments received after
this date will be considered if it is practical to do so, but the
Commission is able to ensure consideration only for comments received
before this date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2019-0173. Address
questions about NRC docket IDs in Regulations.gov to Jennifer Borges;
telephone: 301-287-9127; email: [email protected]. For technical
questions, contact the individual listed in the FOR FURTHER INFORMATION
CONTACT section of this document.
Mail comments to: Office of Administration, Mail Stop:
TWFN-7-A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001, ATTN: Program Management, Announcements and Editing Staff.
For additional direction on obtaining information and
submitting comments, see ``Obtaining Information and Submitting
Comments'' in the SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Jennifer A. Davis, Office of Nuclear
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission,
[[Page 65425]]
Washington, DC 20555-0001, telephone: 301-415-3835; email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2019-0173 when contacting the NRC
about the availability of information regarding this document. You may
obtain publicly-available information related to this document by any
of the following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0173.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the NRC
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the
search, select ``Begin Web-based ADAMS Search.'' For problems with
ADAMS, please contact the NRC's Public Document Room (PDR) reference
staff at 1-800-397-4209, 301-415-4737, or by email to
[email protected]. The ADAMS accession number for each document
referenced in this document (if that document is available in ADAMS) is
provided the first time that a document is referenced. SHINE Medical
Technologies, LLC's (SHINE) operating license application for the SHINE
Medical Isotope Production Facility can be found in ADAMS under Package
Accession No. ML19211C143.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
Library: A copy of the SHINE supplemental environmental
report (ER) is available at the Hedberg Public Library, 316 South Main
Street, Janesville, Wisconsin 53545.
B. Submitting Comments
Please include Docket ID NRC-2019-0173 in the subject line of your
comment submission in order to ensure that the NRC is able to make your
comment submission available to the public in this docket.
The NRC cautions you not to include identifying or contact
information that you do not want to be publicly disclosed in your
comment submission. The NRC will post all comment submissions at
https://www.regulations.gov as well as enter the comment submissions
into ADAMS. The NRC does not routinely edit comment submissions to
remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment submissions into ADAMS.
II. Discussion
By letter dated July 17, 2019 (ADAMS Accession No. ML19211C044),
SHINE filed with the NRC, pursuant to Section 103 of the Atomic Energy
Act and part 50, ``Domestic Licensing of Production and Utilization
Facilities,'' of title 10 of the Code of Federal Regulations (10 CFR),
an application for a 30-year operating license for the SHINE Medical
Isotope Production Facility to be located in Janesville, Wisconsin
(ADAMS Package Accession No. ML19211C143). In addition to general and
financial information, the application included a final safety analysis
report and a supplemental ER. A notice of receipt and availability of
this application was previously published in the Federal Register (FR)
on September 10, 2019 (84 FR 47557). A notice of acceptance of the
application for docketing was published in the FR on October 15, 2019
(84 FR 55187). In accordance with the provisions of 10 CFR 2.105,
``Notice of proposed action,'' a separate notice of opportunity to file
a petition for leave to intervene in a hearing will be published at a
later date.
SHINE has proposed to construct and operate a facility in
Janesville, Wisconsin to produce molybdenum-99 through the irradiation
and processing of a uranyl sulfate solution. As described in the
operating license application, the proposed SHINE facility would
comprise an irradiation facility and radioisotope production facility.
The irradiation facility would consist of eight subcritical operating
assemblies (or irradiation units) and the radioisotope production
facility would consist of hot cell structures for the processing of
irradiated material.
By letters dated March 26 and May 31, 2013 (ADAMS Accession Nos.
ML13088A192 and ML13172A361, respectively), SHINE (at the time known as
SHINE Medical Technologies, Inc.) submitted a construction permit
application, as updated in 2015, for its eight utilization facilities
and one production facility (ADAMS Package Accession No. ML15258A431).
The NRC issued Construction Permit No. CPMIF-001 to SHINE on February
29, 2016 (ADAMS Package Accession No. ML16041A473), as supported by
NUREG-2189, ``Safety Evaluation Report Related to SHINE Medical
Technologies, Inc. Construction Permit Application for a Medical
Radioisotope Production Facility,'' dated August 2016 (ADAMS Accession
No. ML16229A140), and NUREG-2183, ``Environmental Impact Statement for
the Construction Permit for the SHINE Medical Radioisotope Production
Facility,'' dated October 2015 (ADAMS Accession No. ML15288A046). In
accordance with 10 CFR 51.95(b), in connection with SHINE's operating
license application, the NRC will prepare a supplement to NUREG-2183,
which will update the prior environmental review. The supplement will
only cover matters that differ from or reflect significant new
information concerning matters discussed in NUREG-2183.
III. Request for Comments
This notice informs the public of the NRC's intention to conduct
scoping and prepare a supplement to NUREG-2183 as part of the review of
the SHINE operating license application, and to provide the public an
opportunity to participate in the environmental scoping process, as
defined in 10 CFR 51.29, ``Scoping-environmental impact statement and
supplement to environmental impact statement.''
The regulations in 36 CFR 800.8, ``Coordination with the National
Environmental Policy Act,'' allow agencies to use their National
Environmental Policy Act of 1969 (NEPA) process to fulfill the
requirements of Section 106 of the National Historic Preservation Act
(NHPA). Therefore, pursuant to 36 CFR 800.8(c), the NRC intends to use
its NEPA process and documentation to comply with Section 106 of the
NHPA in lieu of the procedures set forth at 36 CFR 800.3 through 800.6.
In accordance with 10 CFR 51.53(b), SHINE submitted a supplement to
its construction permit ER as part of the operating license
application. The supplement updates the information presented in the
previous ER submitted as part of the construction permit application.
The supplemental ER was prepared pursuant to 10 CFR part 51 and is
publicly available in ADAMS under Accession No. ML19211C139. The
supplemental ER may also be viewed on the internet at https://www.nrc.gov/docs/ML1921/ML19211C139.pdf. In addition, a paper
[[Page 65426]]
copy of ER is available for public review at the Hedberg Public
Library, 316 South Main Street, Janesville, Wisconsin 53545.
When a FEIS has been prepared in connection with the issuance of a
construction permit for a production or utilization facility, the NRC
is required to prepare a supplement to the FEIS on the construction
permit in connection with the issuance of an operating license in
accordance with 10 CFR 51.95(b). The supplement will only cover matters
that differ from the final environmental impact statement or that
reflect significant new information concerning matters discussed in the
final environmental impact statement.
The NRC will first conduct scoping and will then prepare a draft
supplement for public comment. Participation in the scoping process by
members of the public and local, State, Tribal, and Federal government
agencies is encouraged. The scoping process will be used to accomplish
the following:
a. Define the proposed action;
b. Determine the scope and identify the significant issues to be
analyzed in depth;
c. Identify and eliminate from detailed study those issues that are
peripheral or are not significant; or were covered by a prior
environmental review;
d. Identify any environmental assessments and other ElSs that are
being or will be prepared that are related to, but are not part of, the
scope of the supplement being considered;
e. Identify other environmental review and consultation
requirements related to the proposed action;
f. Indicate the relationship between the timing of the preparation
of the environmental analyses and the Commission's tentative planning
and decision-making schedule;
g. Identify any cooperating agencies and, as appropriate, allocate
assignments for preparation and schedules for completing the
supplement; and
h. Describe how the supplement will be prepared, including any
contractor assistance to be used.
The NRC invites the following entities to participate in scoping:
a. The applicant, SHINE;
b. Any Federal agency that has jurisdiction by law or special
expertise with respect to any environmental impact involved or that is
authorized to develop and enforce relevant environmental standards;
c. Affected State and local government agencies, including those
authorized to develop and enforce relevant environmental standards;
d. Any affected Indian Tribe;
e. Any person who requests or has requested an opportunity to
participate in the scoping process; and
f. Any person who has petitioned or intends to petition for leave
to intervene under 10 CFR 2.309.
IV. Public Scoping Meeting
In accordance with 10 CFR 51.26, the scoping process may include a
public scoping meeting to help identify significant issues related to a
proposed activity and to determine the scope of issues to be addressed.
The NRC will hold a public scoping meeting for the SHINE environmental
review on December 12, 2019, from 6:00 p.m. to 8:00 p.m. at The Celtic
House at Glen Erin Golf Club, 1417 W Airport Rd., Janesville, WI 53546.
There will be an open house one hour before the meeting for members of
the public to meet with the NRC staff and sign in to speak at the
meeting.
The meeting will be transcribed and will include: (1) An overview
by the NRC staff of the safety and NEPA environmental review processes,
the proposed scope of the supplement to the FEIS; and (2) the
opportunity for interested government agencies, organizations, and
individuals to submit comments or suggestions on the environmental
issues or the proposed scope. The main objectives of this meeting are
to describe the environmental review process and receive public
comments on the appropriate scope and content to be considered in the
staff's review. To be considered, comments must be provided either at
the transcribed public meeting or in writing, as discussed in the
ADDRESSES section of this document.
Persons may register to attend or present oral comments at the
meeting on the scope of the NEPA review by contacting the NRC
Environmental Project Manager, Ms. Jennifer Davis, by telephone at 301-
415-3835, or by email at [email protected] no later than December
5, 2019. Members of the public may also register to speak during the
registration period prior to the start of the meeting. Individual oral
comments may be limited by the time available, depending on the number
of persons who register. Members of the public who have not registered
may also have an opportunity to speak if time permits. Public comments
will be considered in the scoping process for the SHINE environmental
review. Please contact Ms. Davis no later than December 5, 2019, if
accommodations or special equipment is needed to attend or present
information at the public meeting, so that the NRC staff can determine
whether the request can be accommodated.
Participation in the scoping process does not entitle participants
to become parties to the proceeding to which the supplement relates.
Matters related to participation in any hearing are outside the scope
of matters to be discussed at this public meeting.
Dated at Rockville, Maryland, this 22nd day of November 2019.
For the Nuclear Regulatory Commission.
Robert B. Elliott,
Chief, Environmental Review License Renewal Branch, Division of
Rulemaking, Environmental, and Financial Support, Office of Nuclear
Material Safety and Safeguards.
[FR Doc. 2019-25788 Filed 11-26-19; 8:45 am]
BILLING CODE 7590-01-P
